Viracta Therapeutics (VIRX) announced that the company has terminated its employees and will wind down operations. The company is also exploring potential strategic alternatives for its development programs. The board of directors appointed Craig R. Jalbert, age 63, as the Company’s CEO, President, CFO, Treasurer and Corporate Secretary, and sole member of the board to implement the wind down. Mr. Jalbert has served as a principal of the Foxborough, Massachusetts accounting firm of Verdolino & Lowey, P.C. since 1987. For over 30 years he has focused his practice in distressed businesses and has served, and continues to serve, in the capacities of officer and director for numerous firms in their wind-down phases.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIRX:
- Viracta Therapeutics Announces Wind-Down and Leadership Changes
- Netflix draws big viewership for NFL Christmas games: Morning Buzz
- ServiceTitan initiated, Viracta downgraded: Wall Street’s top analyst calls
- Viracta Therapeutics downgraded to Neutral from Buy at Rodman & Renshaw
- Viracta Therapeutics Explores Strategic Options After NAVAL-1 Closure
Questions or Comments about the article? Write to editor@tipranks.com